```html

Fetal Macrosomia – Comprehensive Medical Guide

Overview

Fetal macrosomia is defined as a newborn with an estimated birth weight of ≥ 4,000 g (8 lb 13 oz) regardless of gestational age, or ≥ 4,500 g (9 lb 15 oz) in some clinical definitions. It reflects accelerated fetal growth and can occur in otherwise healthy pregnancies.

While any pregnant person can develop a macrosomic fetus, it is more common in:

• Women with pre‑gestational or gestational diabetes.
• Women who are overweight or obese before pregnancy (BMI ≥ 30 kg/m²).
• Those who gain excessive weight during pregnancy.
• Multiparous women (having had previous births).
• Those with a family history of large babies.

In the United States, macrosomia affects roughly 8–10 % of term births (CDC, 2022). The prevalence is rising parallel to increasing rates of obesity and diabetes worldwide (WHO, 2023).

Symptoms

Because macrosomia is a condition of the fetus, the mother does not experience symptoms per se. However, certain maternal signs may hint at a large baby:

• Rapid fundal height increase – the uterus grows faster than expected for gestational age.
• Excessive fetal movement (subjective hyperkinesia) – may be reported in the third trimester.
• Maternal abdominal discomfort due to overdistension.
• Difficulty fitting the fetus into standard ultrasound windows – sonographer notes limited acoustic windows.

During labor, signs that a baby may be macrosomic include:

• Failure of the head to descend despite strong uterine contractions.
• Prolonged second stage of labor.
• Fetal heart‑rate patterns suggestive of shoulder compression.

Causes and Risk Factors

Maternal Metabolic Factors

• Pre‑gestational diabetes (type 1 or type 2) – high maternal glucose crosses the placenta, stimulating fetal insulin production (a growth factor).
• Gestational diabetes mellitus (GDM) – especially when poorly controlled.
• Maternal obesity – excess adipose tissue contributes to insulin resistance.

Genetic and Demographic Factors

• Male fetus (generally larger than female).
• Parental height and body habitus – tall parents tend to have larger babies.
• Ethnicity – higher rates reported among African‑American and Hispanic populations in the U.S.

Obstetric History

• Previous delivery of a macrosomic infant.
• Multiparity – uterine muscles stretch more with each pregnancy.

Prenatal Care Factors

• Excessive gestational weight gain (GWG) – > 14 kg (30 lb) in women with normal BMI, and proportionally more in overweight/obese women (Institute of Medicine guidelines).
• Late‑term or post‑term pregnancy (≥ 42 weeks) – continued growth beyond 40 weeks.

Diagnosis

Fetal macrosomia is usually suspected prenatally and confirmed after delivery. The assessment combines clinical estimation and imaging.

Clinical Estimation

• Fundal height measurement – measured in centimeters from pubic bone to top of uterus; a discrepancy of > 2 cm from expected can raise suspicion.
• Maternal weight gain pattern – rapid gain in the third trimester warrants closer monitoring.

Ultrasound Assessment

Ultrasound provides the most objective estimate of fetal weight (EFW). The most used formulas incorporate:

• Head circumference (HC)
• Abdominal circumference (AC) – the single most predictive parameter for macrosomia.
• Femur length (FL)

Accuracy varies; a 10 % error margin is common. An EFW ≥ 4,000 g after 36 weeks is considered high risk for macrosomia (Mayo Clinic).

Other Tests

• Oral Glucose Tolerance Test (OGTT) – screens for gestational diabetes, a key driver of macrosomia.
• Maternal HbA1c – assesses overall glycemic control in diabetic pregnancies.

Treatment Options

Management focuses on minimizing delivery complications while supporting fetal health.

Maternal Lifestyle & Glycemic Control

• Nutrition counseling – balanced diet with appropriate caloric intake (typically 300–350 kcal extra per day in the second half of pregnancy).
• Physical activity – 150 minutes of moderate‑intensity aerobic exercise per week, unless contraindicated.
• Blood‑glucose monitoring – for diabetic mothers, target fasting < 95 mg/dL and 1‑hour post‑prandial < 140 mg/dL.

Pharmacologic Management

• Insulin therapy – preferred for diabetic pregnancies when diet alone fails; it reduces fetal hyperinsulinemia and macrosomia risk.
• Metformin – increasingly used in gestational diabetes; data suggest modest reduction in birth weight, though long‑term infant outcomes are still under study (NEJM, 2020).

Delivery Planning

• Timing – most clinicians aim for delivery at 39 weeks for macrosomic fetuses to avoid post‑term growth.
• Mode of delivery –
  • Vaginal delivery*: possible if estimated weight < 4,500 g, pelvis adequate, and no other obstetric contraindications.
  • Cesarean section*: often recommended when estimated weight ≥ 5,000 g (non‑diabetic) or ≥ 4,500 g (diabetic) due to higher shoulder‑dystocia risk (CDC, 2021).
• Operative vaginal delivery – use of forceps or vacuum is generally avoided in suspected macrosomia because of shoulder‑dystocia risk.

Intrapartum Management

• Continuous fetal heart‑rate monitoring.
• Preparedness for shoulder dystocia: instruction of the obstetric team in maneuvers (McRoberts, suprapubic pressure, Wood’s screw, posterior arm delivery).

Living with Fetal Macrosomia

For expecting parents, the diagnosis can be anxiety‑provoking. Below are practical tips to navigate the remainder of pregnancy.

Nutrition & Weight Management

• Track weight gain with a prenatal log; aim to stay within IOM guidelines.
• Choose high‑quality protein, whole grains, fruits, and vegetables over processed carbs and sugary beverages.

Blood‑Sugar Monitoring (if diabetic)

• Test fasting and 2‑hour post‑meal glucose 4‑6 times daily as prescribed.
• Keep a logbook; discuss trends with your obstetrician or diabetes educator.

Physical Activity

• Prenatal yoga, swimming, or brisk walking are low‑impact options.
• Avoid activities with high risk of abdominal trauma.

Preparing for Delivery

• Attend a childbirth class that includes discussion of shoulder dystocia.
• Ask your provider about the hospital’s protocol for macrosomic deliveries.
• Consider a birth plan that outlines preferences for monitoring and possible cesarean.

Post‑Delivery Care

• Newborns may undergo glucose monitoring for hypoglycemia in the first 24 hours.
• Breast‑feeding is encouraged; early skin‑to‑skin contact helps stabilize glucose.
• Schedule a pediatric follow‑up within the first week to assess weight trends.

Prevention

While not all cases are preventable, risk can be markedly reduced by:

• Optimizing pre‑pregnancy weight – aim for a BMI of 18.5–24.9 kg/m².
• Early screening for diabetes – complete OGTT at 24‑28 weeks, earlier if risk factors present.
• Managing gestational weight gain – use the IOM charts tailored to pre‑pregnancy BMI.
• Adopting a balanced diet – limit simple sugars and saturated fats; emphasize fiber‑rich foods.
• Regular physical activity – moderate exercise reduces insulin resistance.
• Close prenatal follow‑up – timely detection of rapid fetal growth allows for proactive planning.

Complications

Both mother and baby face higher risks when macrosomia is present.

Maternal Complications

• Shoulder dystocia – occurs in 1–3 % of deliveries but risk increases to 6–10 % with macrosomic infants.
• Post‑partum hemorrhage – due to uterine atony from overdistended uterus.
• Perineal trauma – higher rates of 3rd‑ or 4th‑degree tears.
• Cesarean delivery – increased likelihood (relative risk 1.8–2.5) and associated surgical complications.

Neonatal Complications

• Birth‑trauma – clavicle fracture, brachial plexus injury (Erb’s palsy).
• Neonatal hypoglycemia – due to excess fetal insulin after cord clamping.
• Respiratory distress – especially if delivered preterm.
• Obesity & metabolic syndrome later in life – epidemiologic link between macrosomia and childhood obesity.

When to Seek Emergency Care

```